46
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Translational Pharmacology and HIV Reservoir Eradication Strategies

, &
Pages 631-633 | Received 03 Aug 2017, Accepted 08 Aug 2017, Published online: 20 Oct 2017
 

Financial & competing interests disclosure

G Morse was supported in part by the National Institute of Allergy and Infectious Diseases of the NIH under Award Number UM1 AI068634, UM1 AI068636 and UM1 AI106701 and by the National Center for Advancing Translational Sciences of the National Institutes of Health under award Number 1UL1TR001412–01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Q Ma was supported in part by K08MH098794. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.